News

Argenx Discontinues Eye Disease Trial: Impact on Peers

Argenx Discontinues Eye Disease Trial: Impact on Peers

Argenx Discontinues Phase 3 Thyroid Eye Disease Trial

Argenx SE (NASDAQ: ARGX) recently made headlines by announcing the discontinuation of its Phase 3 UplighTED studies. These studies were focused on evaluating efgartigimod subcutaneous (SC) for treating moderate to severe thyroid eye disease (TED) in adults. This decision follows a recommendation from an Independent Data Monitoring Committee (IDMC) which cited concerns about futility.

The IDMC's Recommendation

The IDMC reviewed data from a pre-specified interim analysis conducted on patients who completed the 24-week phase of the studies. Although efgartigimod demonstrated a favorable safety profile with no concerning new safety signals, the committee's suggestion led Argenx to halt the trials.

Understanding the UplighTED Study Design

The design of the UplighTED studies aimed to assess multiple aspects of efgartigimod's performance, including its efficacy, safety, pharmacokinetics, and immunogenicity. The primary goal was to evaluate the percentage of participants who showed a response in proptosis (bulging eyes) after 24 weeks.

Secondary Endpoints

Important secondary endpoints were also established, including the change in proptosis measurements from baseline to week 24, improvements in the Graves' Orbitopathy Quality of Life (GO-QoL) score, and the percentage of participants who experienced resolution of diplopia—both critical indicators of the drug's effectiveness in treating TED.

Market Reactions and Analyst Insights

The announcement has stirred various reactions within the medical and investment communities. William Blair expressed surprise about the trial's discontinuation, highlighting external data associated with Graves' disease that suggested FcRn inhibition could yield significant response rates. This has sparked discussions about potential biological variations between different diseases that may affect therapeutic outcomes.

Impact on Other Companies

Analysts noted that this news could favor other therapies, especially within the IGF-1R antibody class, currently viewed as the most efficacious treatment for TED. For instance, Amgen Inc. (NASDAQ: AMGN) produces Tepezza, the only FDA-approved drug for TED. Furthermore, Viridian Therapeutics Inc. (NASDAQ: VRDN) has a drug in development called veligrotug, with expectations for FDA approval by 2026.

Future Steps for Argenx

With the closure of the studies and the database being locked, Argenx plans to execute a detailed analysis of the collected data. They intend to share findings from the studies at an upcoming medical conference, showcasing their commitment to transparency and ongoing research in the field.

Current Market Performance

As of the time of the news release, shares of argenx have seen a decrease of approximately 4.86%, trading around $835.31. This fluctuation reflects market sentiment following the trial's halt and highlights the volatility often seen in pharmaceutical stocks based on clinical trial outcomes and news.

Frequently Asked Questions

What does it mean that Argenx has discontinued its trial?

The discontinuation indicates that the trial did not meet its expected outcomes, leading to the decision to stop further study of the drug for this specific condition.

How does this affect Viridian Therapeutics?

This development may position Viridian Therapeutics favorably, as it could lead to increased interest in their own therapies for thyroid eye disease.

Will Argenx share any data from the halted trial?

Yes, Argenx plans to analyze the data comprehensively and share results at a future medical meeting.

What are the implications for Amgen Inc.?

Amgen's Tepezza remains the only FDA-approved treatment for TED, and this situation could solidify their position in the market.

What should investors watch for next?

Investors should monitor updates from Argenx regarding the data analysis and future therapeutic developments in the thyroid eye disease space.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

DEFSEC Tackles Nasdaq Bid Price Hurdle with Share Move

Updated Category News Views 63

Navigating Bid Price Deficiency Issues Well, it seems DEFSEC Technologies Inc. found themselves in a tricky spot last week. A nasty gram from Nasdaq’s Listing Qualifications Department pointing out that DEFSEC's shares had dipped below that $1.00 per share requirement for too long—a full 30 business days. Now, don't panic just yet. This isn't about the shares getting...

Continue Reading
RBI Prices $1 Billion of Secured Notes Due 2031, 2036

Updated Category News Views 222

A billion dollars of fresh paper just landed on Restaurant Brands International’s balance-sheet doorstep, and this one deserves more than the usual sleepy glance at a financing release. RBI has priced $500 million of 6.00% senior secured notes due 2031 and another $500 million of 6.40% senior secured notes due 2036. The expected closing date is November 24, 2026,...

Continue Reading
Midea's Cooling Systems Take Center Stage at DCW ME

Updated Category News Views 64

AI Surge Demands Cooler Solutions Alright, who'd guess that data centers would feel the heat—literally—like a welder's furnace in Abu Dhabi? As AI demand burns hotter across the Middle East, data centers are sweating it out against 50°C-plus temperatures. We're talking about some serious pressure on traditional cooling methods that just can’t cut it anymore....

Continue Reading
Bona's 2027 Floorcast Finds Wood and Trust Still Win

Updated Category News Views 202

Floors are turning into a long-game purchase again Gray flooring may be limping toward the exit, but the more important signal in Bona's 2027 Floorcast is that homeowners are thinking less like bargain hunters and more like custodians of an expensive asset. That is a useful read for anybody watching the home-improvement and maintenance landscape. People do not replace a...

Continue Reading
Floating Solar Gets a Serious Test in Central New York

Updated Category News Views 86

A flooded quarry pit outside Cortlandville is getting a second career, and that is more interesting than another solar announcement draped across empty acreage. Third Pillar Power has started construction on Crown City Solar at Suit-Kote Corporation's active Polkville Crushed Stone Facility, pairing a working mine, asphalt plant, and storage terminal with what the...

Continue Reading
Visa Direct Tests Stablecoin Prefunding in Asia-Pacific

Updated Category News Views 41

Cross-border payouts have always had an ugly little problem: money can move digitally in theory, then sit around waiting for banks to wake up in practice. Triple-A’s new collaboration with Visa Direct aims straight at that nuisance in Asia-Pacific, allowing eligible clients to use stablecoins to prefund cross-border payouts while the recipient still gets local currency....

Continue Reading
My Home Delivery's Bold Move in Big & Bulky Sector

Updated Category News Views 177

Redefining Big & Bulky Deliveries with AI Let me tell you, the logistics world isn't for the timid, and My Home Delivery (MHD) is swinging for the fences with their latest tech platform. These folks are rolling out an AI-driven system that promises to turn the bulky goods market on its head. Imagine moving your brand new fridge or that king-size bed across town without...

Continue Reading
Snowhawk Enters Telarus as Digital Demand Gets Serious

Updated Category News Views 84

Telarus just pulled another serious capital partner into the room, and that matters more than the usual law-firm victory lap. Snowhawk Partners has invested in the technology services distributor alongside Columbia Capital, which remains a long-standing partner. Nobody disclosed a valuation, ownership percentage, financing mix, or closing date. Annoying? Sure. But the...

Continue Reading
PSEG Declares $0.67 Fourth-Quarter 2026 Cash Dividend

Updated Category News Views 94

A 67-cent utility dividend rarely sets the tape on fire, and that is precisely the point. Public Service Enterprise Group declared a regular fourth-quarter 2026 common-stock dividend of $0.67 per share, payable on or before December 31 to shareholders of record on December 10. For owners of NYSE:PEG, this is the sort of announcement that belongs in the “steady as she...

Continue Reading
Labcorp's Brazil Trial Push Has Promise and Plenty to Prove

Updated Category News Views 93

Brazilian clinical-trial kit deliveries may soon spend less time tangled in international shipping. That is the practical heart of Labcorp's newly announced collaboration with Grupo Fleury, and frankly, practical is plenty good in this business. Labcorp plans to begin assembling clinical-trial kits locally in Brazil in early 2027, then add laboratory operations by the end...

Continue Reading

Top 5 Most Recently Viewed Articles

Nokia and Microscan Collaborate for Enhanced Optical Networks

Updated Category News Views 262

Nokia and Microscan Join Forces for Optical Network Enhancement Nokia and Microscan have teamed up to create a high-capacity metro and regional optical network in Western India, marking a significant advancement in regional connectivity. This collaboration targets boosting bandwidth and improving overall network reliability for a variety of customers, including...

Continue Reading
Southland Secures $160 Million Credit Facility for Expansion

Updated Category News Views 80

Southland Holdings Enters $160 Million Credit Facility Southland Holdings, Inc. (NYSE American: SLND and SLND WS), recognized as a leader in specialized infrastructure construction services, has successfully closed a new senior secured credit facility valued at $160 million. This new financial arrangement includes an initial draw term loan of $140 million and a delayed...

Continue Reading
Discover the Benefits of the New ezPaycheck Payroll Network

Updated Category News Views 199

Introducing the ezPaycheck Network Version for Businesses The ezPaycheck payroll software has released its 2025 network version, aimed at enhancing productivity for growing companies and remote workers. This update brings numerous advantages, ensuring businesses can efficiently manage payroll, regardless of where their team operates. Key Features of the ezPaycheck Network...

Continue Reading
Nokian Tyres' Profits Surge Amidst Flat Market

Updated Category News Views 60

Profit Spike Fueled by Strategic Moves Amid an insipid global tire market shaking with economic jitters, Nokia’s own Nokian Tyres somehow pulled a rabbit out of a hat. If this isn’t proof that strategy and perseverance pay off, what else is? This Finnish giant just rolled in with earnings that shout, 'We’re doing something right!' Let’s break down how they fared...

Continue Reading
CGI Enhances Veteran Support with MyWWP Connection Portal

Updated Category News Views 139

CGI Partners with Wounded Warrior Project to Help Veterans CGI (TSX: GIB.A) (NYSE: GIB), a leader in IT and business consulting, is proud to announce its collaboration with the Wounded Warrior Project to develop MyWWP, a robust digital portal dedicated to supporting wounded veterans and their families. This enhanced online platform is designed to connect users with...

Continue Reading